• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.29% Nasdaq Down3.25%

    More On 1093.HK



    News & Info


    Analyst Coverage


    • Major Holders
    • Insider Transactions
    • Insider Roster


    CSPC Pharmaceutical Group Limited (1093.HK)

    6.18 Up 0.11(1.81%) Feb 5, 2:59AM EST
    ProfileGet Profile for:
    CSPC Pharmaceutical Group Limited
    Central Plaza
    32nd Floor
    Wan Chai,
    Hong Kong - Map
    Website: http://www.e-cspc.com

    Index Membership:N/A
    Industry:Drug Manufacturers - Major
    Full Time Employees:10,565

    Business Summary 

    CSPC Pharmaceutical Group Limited, an investment holding company, manufactures and sells pharmaceutical products. It offers finished drugs, including NBP series primarily for the acute ischemic stroke; Oulaining series primarily for the treatment of mild to moderate memory and mental impairment resulting from vascular dementia, senile dementia, and brain trauma; Xuanning principally for hypertension; Duomeisu, a chemotherapy drug for the treatment of lymphoma, multiple myeloma, and ovarian and breast cancer; Jinyouli for the prevention of leucopenia and infection induced by chemotherapy; and Ailineng primarily for the treatment of nerve glioma and brain metastases, and adjuvant treatment of malignant pleural and peritoneal effusion. The company also provides generic drugs, antibiotics, vitamin C products, and caffeine and other drugs; and products, such as benzylpenicillin sodium, ampicillin sodium, cefazolin sodium, cafradin, ceftriaxone, cefotaxime sodium, cefoperazone sodium, amoxicillin capsule, amoxicillin dispersible tablet, amoxicillin granule, etc. In addition, it has 170 products under research and development with focus on the therapeutic areas of cardio-cerebrovascular, diabetes, oncology, neurology, and anti-infective. Further, the company is involved in the provision of pharmaceutical research and development services; sewage and pharmaceutical by-products treatment activities; and trading of pharmaceutical products. It has operations in the People’s Republic of China, other Asian regions, the Americas, Europe, and internationally. The company was formerly known as China Pharmaceutical Group Limited and changed its name to CSPC Pharmaceutical Group Limited in March 2013. CSPC Pharmaceutical Group Limited was founded in 1997 and is based in Wan Chai, Hong Kong.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on CSPC Pharmaceutical Group Limited

    Key Executives 
    Mr. Dongchen Cai , 62
    Exec. Chairman, Chief Exec. Officer, Managing Director and Chairman of Nomination Committee
    Mr. Weidong Pan , 46
    Chief Accountant, Exec. Director and Director of Shijiazhuang Pharmaceutical Group Company Limite
    Mr. Kin Man Chak , 50
    Exec. Director
    Dr. Shunlong Wang Ph.D., 52
    Exec. Director
    Mr. Huaiyu Wang , 53
    Exec. Director
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in HKD.